FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while ...

In "Shared Decision-Making for Agitation in Specialty Care and Disease Trajectory," our experts close out the discussion of ...

The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication ...

FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for ...

A multicomponent approach to vaccination distress works across the lifespan, though how it works depends on age, according to ...

The faculty compare testing strategies across clinical and pharmacy settings. This episode, "HIV Testing Before and During PrEP: Getting It Right," features the faculty walking through baseline and ...

"Starting the HIV PrEP Conversation in Primary Care and Pharmacy" takes up the question of how clinicians and pharmacists can start the PrEP conversation, and who should be having it.

Many patients with atrial fibrillation (AFib) are not receiving any therapy to prevent stroke, and Geoffrey Barnes, MD, ...

Managing a patient’s pain and fear during vaccination is not a courtesy but an expected part of care, argues Anna Taddio, PhD, a professor at the University of Toronto and lead ...

Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more. An oral PCSK9 inhibitor for ...

Adults with overweight or obesity who switched from injectable semaglutide or tirzepatide to once-daily oral semaglutide (Wegovy) lost an average of 4.1% of body weight over 3 mon ...

, explains why the 2026 guideline on vaccine distress treats vaccine pain and fear as a safety issue and what primary care clinicians should know.